Karina Takesaki Miyaji

CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients

Vivian I. Avelino‐Silva, Karina Takesaki Miyaji, Peter W. Hunt et al. · PLoS neglected tropical diseases · 2016 · 69 citations · Full text

CD4/CD8 Ratio Predicts Yellow Fever Vaccine-Induced Antibody Titers in Virologically Suppressed HIV-Infected Patients

Vivian I. Avelino‐Silva, Karina Takesaki Miyaji, Augusto Mathias et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2015 · 44 citations · Full text

Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016)

Alexandre Blikstad Mauro, Éder Gatti Fernandes, Karina Takesaki Miyaji et al. · Revista do Instituto de Medicina Tropical de São Paulo · 2019 · 44 citations · Full text

Vaccine Hesitancy, Covid-19, Preventive Medicine +23

Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more

Karina Takesaki Miyaji, André Machado Luiz, Amanda Nazareth Lara et al. · Human Vaccines & Immunotherapeutics · 2013 · 24 citations · Full text

Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults

Karina Takesaki Miyaji, Vivian I. Avelino‐Silva, Marisol Simões et al. · Revista do Instituto de Medicina Tropical de São Paulo · 2017 · 23 citations · Full text